Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15344215 | 1.00 | ALDH1A1 (0.58) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL62195 | 0.95 | ALDH1A1 (0.62) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| Tromethamine SCHEMBL6650570 | 0.93 | ALDH1A1 (0.51) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL13294304 | 0.92 | ALDH1A1 (0.59) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL490468 | 0.91 | ALDH1A1 (0.49) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL17212248 | 0.91 | ALDH1A1 (0.58) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL27034976 | 0.91 | PRSS1 (0.57) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL13852877 | 0.90 | ALDH1A1 (0.57) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL18516874 | 0.90 | ALDH1A1 (0.57) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 | |
| SCHEMBL15328854 | 0.90 | ALDH1A1 (0.57) | ALDH1A1CYP3A4LMNAHSD17B10MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2921157-B1 | Coated titanium dioxide to reduce whitening effect on skin | SYMRISE AG (DE) | 2017-08-16 | — | — | EP | disclosed |
| EP-2185126-B1 | USE OF TROXERUTIN TO QUENCH THE FLUORESCENCE OF DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE | SYMRISE AG (DE) | 2017-06-21 | — | — | EP | disclosed |
| US-9517190-B2 | Coated titanium dioxide to reduce the whitening effect on skin | SYMRISE AG (DE) | 2016-12-13 | — | — | US | disclosed |
| EP-2178493-B2 | Stable soluble salts of phenylbenzimidazole sulfonic acid at pH 6.0 to below 6.8 | SYMRISE AG (DE) | 2015-12-09 | — | — | EP | disclosed |
| US-20150265510-A1 | COATED TITANIUM DIOXIDE TO REDUCE THE WHITENING EFFECT ON SKIN | SYMRISE AG (DE) | 2015-09-24 | — | — | US | disclosed |
| EP-2921157-A1 | Coated titanium dioxide to reduce whitening effect on skin | Symrise AG (DE) | 2015-09-23 | — | — | EP | disclosed |
| US-8440172-B2 | Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0 | SYMRISE AG (DE) | 2013-05-14 | — | — | US | disclosed |
| EP-2178493-B1 | Stable soluble salts of phenylbenzimidazole sulfonic acid at pH 6.0 to below 6.8 | SYMRISE AG (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20100183531-A1 | STABLE SOLUBLE SALTS OF PHENYLBENZIMIDAZOLE SULFONIC ACID AT PHS AT OR BELOW 7.0 | SYMRISE GMBH & CO. KG (DE) | 2010-07-22 | — | — | US | disclosed |
| EP-2185126-A2 | USE OF TROXERUTIN TO QUENCH THE FLUORESCENCE OF DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE | Symrise GmbH & Co. KG (DE) | 2010-05-19 | — | — | EP | disclosed |
| WO-2007135197-A2 | USE OF BENZOPHENONE-4 AND ITS SALTS TO QUENCH THE FLUORESCENCE OF DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE | SYMRISE GMBH & CO. KG (DE) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007128840-A2 | USE OF TROXERUTIN TO QUENCH THE FLUORESCENCE OF DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE | SYMRISE GMBH & CO. KG (DE) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150265510-A1 | COATED TITANIUM DIOXIDE TO REDUCE THE WHITENING EFFECT ON SKIN | FASN, ALOX12, CUTA | ALDH1A1 252/4885CYP3A4 502/4885LMNA 2058/4885 |
| US-20100183531-A1 | STABLE SOLUBLE SALTS OF PHENYLBENZIMIDAZOLE SULFONIC ACID AT PHS AT OR BELOW 7.0 | TYR, H1-5, PAH | ALDH1A1 2231/4885CYP3A4 1191/4885LMNA 3887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.